{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:15:49Z","timestamp":1648761349799},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00393-020-00815-1","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T13:02:28Z","timestamp":1590584548000},"page":"578-583","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Muskelschw\u00e4che und CK\u2011Erh\u00f6hung: Ist es immer eine\u00a0Myositis?"],"prefix":"10.1007","volume":"79","author":[{"given":"A.","family":"Kernder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Mucke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.-S.","family":"Moldovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Albrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Neuen-Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,27]]},"reference":[{"key":"815_CR1","unstructured":"Deschauer M (2016) S1-Leitlinie Diagnostik von Myopathien. www.dgn.org\/leitlinien. Zugegriffen: 2. Aug. 2019 (Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie)"},{"issue":"5","key":"815_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1055\/s-0029-1220337","volume":"36","author":"B Schoser","year":"2009","unstructured":"Schoser\u00a0B (2009) Update on phenotypes of hereditary myopathies and indication for a\u00a0muscle biopsy. Akt Neurol 36(5):221\u2013226","journal-title":"Akt Neurol"},{"key":"815_CR3","volume-title":"Neuromuscular disorders: management and therapy","author":"M Vorgerd","year":"2011","unstructured":"Vorgerd\u00a0M, Deschauer\u00a0M (2011) Management and treatment of hereditary metabolic myopathies. In: Neuromuscular disorders: management and therapy. Elsevier, Amsterdam"},{"issue":"2","key":"815_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/mus.24642","volume":"52","author":"T Chung","year":"2015","unstructured":"Chung\u00a0T, Christopher-Stine\u00a0L, Paik\u00a0JJ, Corse\u00a0A, Mammen\u00a0AL (2015) The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy. Muscle Nerve 52(2):189\u2013195","journal-title":"Muscle Nerve"},{"issue":"4","key":"815_CR5","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1212\/NXI.0000000000000124","volume":"2","author":"A Alshehri","year":"2015","unstructured":"Alshehri\u00a0A, Choksi\u00a0R, Bucelli\u00a0R, Pestronk\u00a0A (2015) Myopathy with anti-HMGCR antibodies: Perimysium and myofiber pathology. Neurol Neuroimmunol Neuroinflamm 2(4):e124","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"7","key":"815_CR6","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1056\/NEJMra1515161","volume":"374","author":"AL Mammen","year":"2016","unstructured":"Mammen\u00a0AL (2016) Statin-associated autoimmune myopathy. N\u00a0Engl J Med 374(7):664\u2013669","journal-title":"N Engl J Med"},{"issue":"2","key":"815_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/mus.21486","volume":"41","author":"P Grable-Esposito","year":"2010","unstructured":"Grable-Esposito\u00a0P, Katzberg\u00a0HD, Greenberg\u00a0SA, Srinivasan\u00a0J, Katz\u00a0J, Amato\u00a0AA (2010) Immune-mediated necrotizing myopathy associated with statins. Muscle Nerve 41(2):185\u2013190","journal-title":"Muscle Nerve"},{"issue":"3","key":"815_CR8","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/art.30156","volume":"63","author":"AL Mammen","year":"2011","unstructured":"Mammen\u00a0AL, Chung\u00a0T, Christopher-Stine\u00a0L, Rosen\u00a0P, Rosen\u00a0A, Doering\u00a0KR et al (2011) Autoantibodies against 3\u2011hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum 63(3):713\u2013721","journal-title":"Arthritis Rheum"},{"issue":"4","key":"815_CR9","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/ana.24902","volume":"81","author":"L Arouche-Delaperche","year":"2017","unstructured":"Arouche-Delaperche\u00a0L, Allenbach\u00a0Y, Amelin\u00a0D, Preusse\u00a0C, Mouly\u00a0V, Mauhin\u00a0W et al (2017) Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies. Ann Neurol 81(4):538\u2013548","journal-title":"Ann Neurol"},{"issue":"3","key":"815_CR10","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1172\/JCI111265","volume":"73","author":"RL Sabina","year":"1984","unstructured":"Sabina\u00a0RL, Swain\u00a0JL, Olanow\u00a0CW, Bradley\u00a0WG, Fishbein\u00a0WN, DiMauro\u00a0S et\u00a0al (1984) Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle. J\u00a0Clin Invest 73(3):720\u2013730","journal-title":"J Clin Invest"},{"issue":"16","key":"815_CR11","doi-asserted-by":"crossref","first-page":"9423","DOI":"10.1016\/S0021-9258(19)38866-0","volume":"265","author":"RL Sabina","year":"1990","unstructured":"Sabina\u00a0RL, Morisaki\u00a0T, Clarke\u00a0P, Eddy\u00a0R, Shows\u00a0TB, Morton\u00a0CC et\u00a0al (1990) Characterization of the human and rat myoadenylate deaminase genes. J\u00a0Biol Chem 265(16):9423\u20139433","journal-title":"J Biol Chem"},{"issue":"27","key":"815_CR12","doi-asserted-by":"publisher","first-page":"25589","DOI":"10.1074\/jbc.M011637200","volume":"276","author":"T Genetta","year":"2001","unstructured":"Genetta\u00a0T, Morisaki\u00a0H, Morisaki\u00a0T, Holmes\u00a0EW (2001) A novel bipartite intronic splicing enhancer promotes the inclusion of a\u00a0mini-exon in the AMP deaminase 1 gene. J\u00a0Biol Chem 276(27):25589\u201325597","journal-title":"J Biol Chem"},{"issue":"14","key":"815_CR13","doi-asserted-by":"publisher","first-page":"6457","DOI":"10.1073\/pnas.89.14.6457","volume":"89","author":"T Morisaki","year":"1992","unstructured":"Morisaki\u00a0T, Gross\u00a0M, Morisaki\u00a0H, Pongratz\u00a0D, Z\u00f6llner\u00a0N, Holmes\u00a0EW (1992) Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc Natl Acad Sci U S\u00a0A 89(14):6457\u20136461","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"815_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/0006-2944(85)90024-9","volume":"33","author":"WN Fishbein","year":"1985","unstructured":"Fishbein\u00a0WN (1985) Myoadenylate deaminase deficiency: inherited and acquired forms. Biochem Med 33(2):158\u2013169","journal-title":"Biochem Med"},{"issue":"23","key":"815_CR15","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/BF01716208","volume":"67","author":"M Gross","year":"1989","unstructured":"Gross\u00a0M, Reiter\u00a0S, Z\u00f6llner\u00a0N (1989) Metabolism of D\u2011ribose administered continuously to healthy persons and to patients with myoadenylate deaminase deficiency. Klin Wochenschr 67(23):1205\u20131213","journal-title":"Klin Wochenschr"},{"issue":"24","key":"815_CR16","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/BF01785710","volume":"64","author":"N Z\u00f6llner","year":"1986","unstructured":"Z\u00f6llner\u00a0N, Reiter\u00a0S, Gross\u00a0M, Pongratz\u00a0D, Reimers\u00a0CD, Gerbitz\u00a0K et\u00a0al (1986) Myoadenylate deaminase deficiency: successful symptomatic therapy by high dose oral administration of ribose. Klin Wochenschr 64(24):1281\u20131290","journal-title":"Klin Wochenschr"},{"issue":"7","key":"815_CR17","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s00393-017-0326-0","volume":"76","author":"G Ceccon","year":"2017","unstructured":"Ceccon\u00a0G, Lehmann\u00a0HC, Neuen-Jacob\u00a0E, Meng\u00a0G, Fink\u00a0GR, Wunderlich\u00a0G (2017) \u201cTherapy-resistant polymyositis\u201d\u2014is the diagnosis correct? Z\u00a0Rheumatol 76(7):640\u2013643","journal-title":"Z Rheumatol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-020-00815-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-020-00815-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-020-00815-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T23:38:41Z","timestamp":1622072321000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-020-00815-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,27]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["815"],"URL":"https:\/\/doi.org\/10.1007\/s00393-020-00815-1","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,27]]},"assertion":[{"value":"27 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.\u00a0Kernder, J.\u00a0Mucke, A.-S.\u00a0Moldovan, P.\u00a0Albrecht, E.\u00a0Neuen-Jacob und M.\u00a0Schneider geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}